Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Calcium supplements. |
| Generic Name : | Generic - cardiovascular system |
| Drug description : | Sterile solution for slow intravenous infusion in prefilled syringe. |
| Presentation : | Infusion, calcium chloride 10% w/ v. |
| Indications : | Calcium chloride injection is indicated for use in cardio- pulmonary resuscitation where there is also hyperkalaemia or hypocalcaemia or calcium channel block toxicity. |
| Adult Dosage : | Single dose of 10mL (10% w/v). Refer to Summary of Product Characteristics. |
| Child Dosage : | Not recommended. |
| Contra Indications : | Parenteral calcium therapy is contraindicated in patients receiving cardiac glycosides. Give cautiously to patients with impaired renal function, cardiac disease, or sarcoidosis. Calcium chloride, because of its acidifying nature, is unsuitable for the treatment of hypocalcaemia caused by renal insufficiency or in patients with respiratory acidosis or failure. |
| Special Precautions : | Excessive amounts of calcium salts may cause hypercalcaemia. Careful monitoring of serum electrolyte concentrations is essential throughout therapy. Parenteral administration may cause local reactions at the injection site and soft tissue calcification. Calcium Chloride is generally considered to be the most irritant of the commonly used calcium salts. Care should be taken to prevent extravasation during intravenous injection. Calcium chloride, must be administered slowly through the vein. Too rapid intravenous injection may lead to symptoms of hypercalcaemia. |
| Interactions : | Bisphosphonates, tetracyclines, diuretics (eg, thiazides), cardiac glycosides (digoxin and digitoxin). |
| Adverse Reactions : | Injection can produce irritation. Soft tissue calcification has also been reported following parenteral administration of calcium salts. Hypercalcaemia. Symptoms of hypercalcaemia may include anorexia, nausea, vomiting, constipation, abdominal pain, muscle weakness, mental disturbances, polydipsia, polyuria, bone pain, nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma. Too rapid intravenous injection of calcium salts may also lead to many of the symptoms of hypercalcaemia as well as a chalky taste, hot flushes and peripheral vasodilation. |
| Manufacturer : | Aurum |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org